Kymera Therapeutics Stock Volatility Indicators True Range

KYMR Stock  USD 30.25  5.11  14.45%   
Kymera Therapeutics volatility indicators tool provides the execution environment for running the True Range indicator and other technical functions against Kymera Therapeutics. Kymera Therapeutics value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of volatility indicators indicators. As with most other technical indicators, the True Range indicator function is designed to identify and follow existing trends. Kymera Therapeutics volatility indicators enable investors to predict price movements based on how different True Range indicators change over time.

Indicator
The output start index for this execution was one with a total number of output elements of sixty. The True Range is a measure of Kymera Therapeutics volatility developed by Welles Wilder.
JavaScript chart by amCharts 3.21.15Dec2025FebJan 20Jan 27FebFeb 10Feb 17Feb 2430354045 200K300K400K500K600K700K800K900K1M1.1M1.2M1.3M1.4M1.5M1.6M1.7M1.8M 1.52.02.53.03.54.04.55.05.56.0 42.6K42.8K43K43.2K43.4K43.6K43.8K44K44.2K44.4K44.6K44.8K Show all
JavaScript chart by amCharts 3.21.15Kymera Therapeutics Volume Kymera Therapeutics Closing Prices Dow Jones Industrial Closing Prices - Benchmark Kymera Therapeutics True Range

Kymera Therapeutics Technical Analysis Modules

Most technical analysis of Kymera Therapeutics help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Kymera from various momentum indicators to cycle indicators. When you analyze Kymera charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Kymera Therapeutics Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Kymera Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Kymera Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Kymera Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Kymera Therapeutics's daily price indicators and compare them against related drivers, such as volatility indicators and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of Kymera Therapeutics's intrinsic value. In addition to deriving basic predictive indicators for Kymera Therapeutics, we also check how macroeconomic factors affect Kymera Therapeutics price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2022 2023 2024 (projected)
Current Ratio8.844.737.53
Net Debt To EBITDA0.340.180.12
Hype
Prediction
LowEstimatedHigh
26.3130.2534.19
Details
Intrinsic
Valuation
LowRealHigh
24.1028.0431.98
Details
Naive
Forecast
LowNextHigh
30.7034.6438.58
Details
20 Analysts
Consensus
LowTargetHigh
53.7959.1165.61
Details

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Kymera Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Kymera Therapeutics' short interest history, or implied volatility extrapolated from Kymera Therapeutics options trading.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Momentum Idea
Momentum
Invested few shares
Warren Buffett Holdings Idea
Warren Buffett Holdings
Invested over 30 shares
Hedge Favorites Idea
Hedge Favorites
Invested over 60 shares
Banking Idea
Banking
Invested over 30 shares
Cash Cows Idea
Cash Cows
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested over 60 shares
Disruptive Technologies Idea
Disruptive Technologies
Invested few shares
ESG Investing Idea
ESG Investing
Invested few shares
Chemicals Idea
Chemicals
Invested over 30 shares
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 20 shares

Additional Tools for Kymera Stock Analysis

When running Kymera Therapeutics' price analysis, check to measure Kymera Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kymera Therapeutics is operating at the current time. Most of Kymera Therapeutics' value examination focuses on studying past and present price action to predict the probability of Kymera Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kymera Therapeutics' price. Additionally, you may evaluate how the addition of Kymera Therapeutics to your portfolios can decrease your overall portfolio volatility.

Trending Assets

PRLD
Prelude Therapeutics
0.75  -0.06  -7.41 
AGIO
Agios Pharm
34.34  -0.1  -0.29 
IPSC
Century Therapeutics
0.67  -0.02  -2.9 
RVMD
Revolution Medicines
39.08  -1.42  -3.51